SCHEMBL19222886

SCHEMBL19222886

CCOC(=O)[C@H](CO)C[C@@H](CCc1ccc(-c2cccc(F)c2)cc1)NC(=O)OC(C)(C)C

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MME P08473 4/20 0.60
▸ MMP2 P08253 2/20 0.46
▸ MMP3 P08254 2/20 0.46
▸ ACE P12821 1/20 0.41
▸ CTSK P43235 5/20 0.41
▸ CTSS P25774 4/20 0.41
▸ SCN9A Q15858 2/20 0.40
▸ CTSB P07858 1/20 0.37
▸ MMEL1 Q495T6 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.36
▸ POLB P06746 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ PYGL P06737 1/20 0.36
▸ MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11973757 0.91 MME (0.70) MMEMMP2MMP3ACECTSK
SCHEMBL20099589 0.91 MME (0.70) MMEMMP2MMP3ACECTSK
SCHEMBL11969971 0.91 MME (0.70) MMEMMP2MMP3ACECTSK
SCHEMBL20306289 0.86 MME (0.60) MMEMMP2MMP3ACECTSK
SCHEMBL11969628 0.81 MME (0.56) MMEMMP2MMP3ACECTSK
SCHEMBL16930454 0.80 MME (0.55) MMEACEMMEL1ALDH1A1MAPT
SCHEMBL20578496 0.80 MME (0.55) MMEACEMMEL1ALDH1A1MAPT
SCHEMBL18874680 0.80 MME (0.55) MMEACEMMEL1ALDH1A1MAPT
SCHEMBL11970064 0.80 MME (0.54) MMEACECTSKCTSSSCN9A
SCHEMBL11969730 0.80 MME (0.54) MMEACECTSKCTSSSCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9724359-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2017-08-08 — — US disclosed
Send feedback